• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Emory Health Taps DrFirst to Leverage Clinical-Grade AI for Medication Adherence & Affordability

by Jasmine Pennic 11/01/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Emory Healthcare, a comprehensive academic health system in Georgia, is collaborating with healthcare technology pioneer DrFirst to help patients access and adhere to affordable, appropriate prescription medications for their health conditions and ailments. 

– As part of the collaboration, Emory Healthcare will leverage three medication management services offered within Fuzion by DrFirst, a software platform that uses clinical-grade artificial intelligence (AI) to streamline clinical workflows to boost workflow efficiency and medication adherence.

Assist Patients with Medication Adherence and Affordability

Research shows that medication adherence is a primary determinant of success in patient outcomes, while non-adherence can lead to a worsening of diseases and disorders, increased healthcare costs and even death. Key benefits of the collaboration include: 

  • Medication history with clinical-grade AI provides the most comprehensive information available and eliminates the need for manual data entry in workflows. This means patients will have less chance of adverse drug events, clinicians will have more complete data at the point of care, and pharmacists will save time on medication reconciliation, which is the process of making sure the list of medications for a patient matches what the patient is actually taking.
  • Prescription price transparency allows providers to know patients’ pharmacy benefits, including their out-of-pocket costs, before they leave the doctor’s office or hospital. Knowing these costs up front, with options to switch to an affordable therapeutic equivalent if too costly, saves time and money for patients. This increases medication adherence and means patients are less likely to abandon high-cost prescriptions at the pharmacy.
  • Coming soon: Automated messaging will alert patients when their clinician sends an electronic prescription to their pharmacy. The HIPAA-compliant functionality will allow patients to review their prescription and pharmacy information, as well as get relevant educational information and financial savings for their medication.

Patients will automatically benefit from the prescription messaging when they opt-in for communications from Emory. Additionally, patients can choose to opt-out of receiving text messaging alerts.

“The collaboration with DrFirst will put patients first in enhancing medication prescribing and management, from an encounter with the clinician to picking up the prescription at the pharmacy,” says Alistair Erskine, MD, chief information and digital officer for Emory Healthcare. “These clinical solutions will assist our providers with their decisions in providing a higher level of care for our patients.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, DrFirst, Emory Healthcare, Medication Adherence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |